160 related articles for article (PubMed ID: 26981927)
21. Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study.
Rolfs A; Fazekas F; Grittner U; Dichgans M; Martus P; Holzhausen M; Böttcher T; Heuschmann PU; Tatlisumak T; Tanislav C; Jungehulsing GJ; Giese AK; Putaala J; Huber R; Bodechtel U; Lichy C; Enzinger C; Schmidt R; Hennerici MG; Kaps M; Kessler C; Lackner K; Paschke E; Meyer W; Mascher H; Riess O; Kolodny E; Norrving B;
Stroke; 2013 Feb; 44(2):340-9. PubMed ID: 23306324
[TBL] [Abstract][Full Text] [Related]
22. [Stroke and cornea verticillata revealing Fabry's disease in a female].
Fetter D; Bagan-Triquenot A; Guegan-Massardier E; Guyant-Marechal L; Tollard E; Bekri S; Hannequin D
Rev Neurol (Paris); 2012 Feb; 168(2):181-6. PubMed ID: 22033111
[TBL] [Abstract][Full Text] [Related]
23. Fabry disease in the Spanish population: observational study with detection of 77 patients.
Vieitez I; Souto-Rodriguez O; Fernandez-Mosquera L; San Millan B; Teijeira S; Fernandez-Martin J; Martinez-Sanchez F; Aldamiz-Echevarria LJ; Lopez-Rodriguez M; Navarro C; Ortolano S
Orphanet J Rare Dis; 2018 Apr; 13(1):52. PubMed ID: 29631605
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events.
Lanthier S; Saposnik G; Lebovic G; Pope K; Selchen D; Moore DF;
Stroke; 2017 Jul; 48(7):1766-1772. PubMed ID: 28596458
[TBL] [Abstract][Full Text] [Related]
25. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease.
Brouns R; Thijs V; Eyskens F; Van den Broeck M; Belachew S; Van Broeckhoven C; Redondo P; Hemelsoet D; Fumal A; Jeangette S; Verslegers W; Baker R; Hughes D; De Deyn PP;
Stroke; 2010 May; 41(5):863-8. PubMed ID: 20360539
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.
Rolfs A; Böttcher T; Zschiesche M; Morris P; Winchester B; Bauer P; Walter U; Mix E; Löhr M; Harzer K; Strauss U; Pahnke J; Grossmann A; Benecke R
Lancet; 2005 Nov; 366(9499):1794-6. PubMed ID: 16298216
[TBL] [Abstract][Full Text] [Related]
27. Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia.
Fancellu L; Borsini W; Romani I; Pirisi A; Deiana GA; Sechi E; Doneddu PE; Rassu AL; Demurtas R; Scarabotto A; Cassini P; Arbustini E; Sechi G
BMC Neurol; 2015 Dec; 15():256. PubMed ID: 26652600
[TBL] [Abstract][Full Text] [Related]
28. Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease.
Dai X; Zong X; Pan X; Lu W; Jiang GR; Lin F
Orphanet J Rare Dis; 2022 Jun; 17(1):237. PubMed ID: 35725559
[TBL] [Abstract][Full Text] [Related]
29. p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males.
Nakamura K; Sekijima Y; Nakamura K; Hattori K; Nagamatsu K; Shimizu Y; Yazaki M; Sakurai A; Endo F; Fukushima Y; Ikeda SI
Eur J Neurol; 2014; 21(1):49-56. PubMed ID: 23724928
[TBL] [Abstract][Full Text] [Related]
30. Fabry Disease Frequency Among Young Cryptogenic Stroke Patients in the City of Edirne, Turkey.
Güler S
Neurologist; 2021 Jul; 26(4):125-131. PubMed ID: 34190205
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.
Choi JH; Lee BH; Heo SH; Kim GH; Kim YM; Kim DS; Ko JM; Sohn YB; Hong YH; Lee DH; Kook H; Lim HH; Kim KH; Kim WS; Hong GR; Kim SH; Park SH; Kim CD; Kim SM; Seo JS; Yoo HW
Medicine (Baltimore); 2017 Jul; 96(29):e7387. PubMed ID: 28723748
[TBL] [Abstract][Full Text] [Related]
32. Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA.
Sarikaya H; Yilmaz M; Michael N; Miserez AR; Steinmann B; Baumgartner RW
Eur J Neurol; 2012 Nov; 19(11):1421-6. PubMed ID: 22680335
[TBL] [Abstract][Full Text] [Related]
33. A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report.
Pisani A; Imbriaco M; Zizzo C; Albeggiani G; Colomba P; Alessandro R; Iemolo F; Duro G
BMC Cardiovasc Disord; 2012 Jun; 12():39. PubMed ID: 22682330
[TBL] [Abstract][Full Text] [Related]
34. Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant.
Lenders M; Weidemann F; Kurschat C; Canaan-Kühl S; Duning T; Stypmann J; Schmitz B; Reiermann S; Krämer J; Blaschke D; Wanner C; Brand SM; Brand E
Orphanet J Rare Dis; 2016 May; 11(1):54. PubMed ID: 27142856
[TBL] [Abstract][Full Text] [Related]
35. Cerebral hemorrhage in Fabry's disease.
Nakamura K; Sekijima Y; Nakamura K; Hattori K; Nagamatsu K; Shimizu Y; Yasude T; Ushiyama M; Endo F; Fukushima Y; Ikeda S
J Hum Genet; 2010 Apr; 55(4):259-61. PubMed ID: 20300124
[TBL] [Abstract][Full Text] [Related]
36. Fabry Disease Screening in Patients With Kidney Transplant: A Single-Center Study in Turkey.
Erdogmus S; Kutlay S; Kumru G; Ors Sendogan D; Erturk S; Keven K; Ceylaner G; Sengul S
Exp Clin Transplant; 2020 Aug; 18(4):444-449. PubMed ID: 32281532
[TBL] [Abstract][Full Text] [Related]
37. Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset Phenotypes.
Adalsteinsdottir B; Palsson R; Desnick RJ; Gardarsdottir M; Teekakirikul P; Maron M; Appelbaum E; Neisius U; Maron BJ; Burke MA; Chen B; Pagant S; Madsen CV; Danielsen R; Arngrimsson R; Feldt-Rasmussen U; Seidman JG; Seidman CE; Gunnarsson GT
Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28798024
[TBL] [Abstract][Full Text] [Related]
38. Neurological complications of Anderson-Fabry disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
[TBL] [Abstract][Full Text] [Related]
39. Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke.
Brouns R; Sheorajpanday R; Braxel E; Eyskens F; Baker R; Hughes D; Mehta A; Timmerman T; Vincent MF; De Deyn PP
Clin Neurol Neurosurg; 2007 Jul; 109(6):479-84. PubMed ID: 17509753
[TBL] [Abstract][Full Text] [Related]
40. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC
Nephron; 2018; 138(2):147-156. PubMed ID: 28892806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
